Data presented at EAHAD 2026 show product-specific calibration improves factor VIII activity measurement accuracy.
In clinical laboratory settings, coagulation factor tests are routinely conducted to identify inherited or acquired deficiencies in patients suspected of an ongoing bleeding risk. These tests ...
A novel proteomics-based approach for detection of ESR1 mutant peptides in hormone receptor positive metastatic breast cancer: An exploratory study from India. This is an ASCO Meeting Abstract from ...
Different types of assays led to different results in measures of factor IX variant FIX-R338L, the authors found. A new field study could help clinicians better interpret laboratory measurements of ...
The phase 3 trial of valoctocogene roxaparvovec for severe hemophilia A showed it reduced bleeding events as well as the use of factor VIII concentrates. A phase 3 trial of valoctocogene roxaparvovec, ...
DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results